The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index; 11 of the 30 sources its claims cite were checked for support.
IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin
Open accessAbstract
Hypoferremia is a common response to systemic infections or generalized inflammatory disorders.In mouse models, the development of hypoferremia during inflammation requires hepcidin, an iron regulatory peptide hormone produced in the liver, but the inflammatory signals that regulate hepcidin are largely unknown.Our studies in human liver cell cultures, mice, and human volunteers indicate that IL-6 is the necessary and sufficient cytokine for the induction of hepcidin during inflammation and that the IL-6-hepcidin axis is responsible for the hypoferremia of inflammation. Methods Macrophage culture.Monocytes from peripheral blood were isolated by centrifugation through Ficoll-Paque (Amersham Pharmacia Biotech, Piscataway, New Jersey, USA) and 46% iso-Nonstandard abbreviations used: anemia of inflammation (AI); Iscove's modified Dulbecco's medium (IMDM); medium from LPS-stimulated macrophages (M-LPS); medium from unstimulated macrophages (M); recombinant human IL-6 (rhIL-6); total iron-binding capacity (TIBC); unsaturated iron-binding capacity (UIBC). Conflict of interest:The authors have declared that no conflict of interest exists.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
23 Own result · 13 No full text of the sources · 13 Own interpretation · 6 Supported · 3 Partly supported · 1 Couldn’t confirm · 1 No basis given · accuracy not yet measured
Every source the paper cites for this claim was checked and supports it.
In the paper
“patients with AI due to inflammatory disorders or infections had markedly increased excretion of urinary hepcidin”
What the sources say
- Supportedcites [12] source
The Results and discussion report elevated urinary hepcidin excretion in patients diagnosed with anemia of inflammation compared with healthy subjects and other patient groups. The same section reports very high excretion in a patient with epididymitis and sepsis, supporting the infection component of the claim. (LLM, conf=0.93)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“decreased serum iron”
What the sources say
- Supportedcites [8] Nicolas, 2002, J. Clin. Invest. source
The Results section reports a twofold decrease in serum iron in wild-type mice 16 hours after turpentine injection (Figure 6a). It also notes that this decrease was not observed in hepcidin-deficient mice. (LLM, conf=0.95)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“injections of turpentine increased hepcidin mRNA”
What the sources say
- Supportedcites [8] Nicolas, 2002, J. Clin. Invest. source
The Results section reports a sixfold increase in liver hepcidin gene expression 16 hours after turpentine injection compared with saline-injected controls. The discussion (p. 1042) explicitly describes this as a sixfold increase in liver hepcidin mRNA in mice. (LLM, conf=0.95)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“strong induction of hepcidin mRNA by IL-6”
What the sources say
- Supportedcites [12] source
The Results and discussion section reports that IL-6 induced hepcidin in primary human hepatocytes within 8 hours, with a 25-fold increase. The Figure 2 caption identifies the measured signal as hepcidin mRNA. (LLM, conf=0.94)
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“but not IL-1 α or TNFα”
What the sources say
- Supportedcites [12] source
The Results and discussion section reports that IL-1α and TNF-α did not induce hepcidin mRNA within eight hours in primary human hepatocytes, unlike IL-6. It also notes that IL-1α induced hepcidin mRNA after 24 hours, probably indirectly through IL-6; the claim is consistent with the lack of strong direct induction. (LLM, conf=0.90)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“LPS treatment increased hepcidin mRNA levels in primary human hepatocytes”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Anti-TNFα Ab's had no detectable effect in either experiment”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Hep3B hepcidin mRNA, however, markedly increased after exposure to M-LPS”
plaindirectn = 4- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Anti-IL-6 Ab's had similar inhibitory effects when hepatocytes or Hep3B cells were treated with conditioned medium from macrophages exposed to peptidoglycan from Staphylococcus aureus”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in IL-6 KO mice hepcidin mRNA increased ninefold”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Probably not a substantial claim. 10
- It may state two separate claims as one. 17
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“hepcidin synthesis is regulated by dietary iron and iron stores, as well as by tissue oxygenation”
What the sources say
- Not checked — no full text of the sourcecites [3] source
- Partly supportedcites [7] sourceExperimental — accuracy not yet measured
Section 3.4 reports increased liver HEPC1 and HEPC2 transcripts in mice given dietary carbonyl iron or injected iron–dextran, supporting regulation by iron excess. The paper does not establish regulation by iron stores specifically, and no passage addresses tissue oxygenation; it measures gene expression rather than hepcidin synthesis directly. (LLM, conf=0.88)
- Partly supportedcites [8] Nicolas, 2002, J. Clin. Invest. sourceExperimental — accuracy not yet measured
The hypoxia results report that reduced tissue oxygenation downregulated hepcidin gene expression in mice. The anemia results show that iron loading increased expression, and the Discussion links iron deficiency to low expression until stores are repleted. The paper does not show that dietary iron itself regulates hepcidin synthesis; it describes hepcidin regulating dietary iron absorption instead. (LLM, conf=0.87)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“the turpentine-induced hypoferremia was not observed in hepcidin-deficient mice (8), demonstrating that hepcidin is required for iron sequestration during inflammatory conditions”
What the sources say
- Partly supportedcites [8] Nicolas, 2002, J. Clin. Invest. sourceExperimental — accuracy not yet measured
The results and discussion (p. 1042) report that turpentine lowered serum iron in wild-type mice but not in hepcidin-deficient mice. They establish hepcidin’s role in the inflammatory fall in serum iron, but describe iron sequestration as a proposed mechanism, not one directly demonstrated by that experiment. (LLM, conf=0.84)
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“hepcidin mRNA expression was increased in mice with dietinduced or genetically induced iron overload”
What the sources say
- Not checked — no full text of the sourcecites [3] source
- Partly supportedcites [7] sourceExperimental — accuracy not yet measured
Section 3.4 reports increased liver HEPC1 and HEPC2 transcripts in mice given dietary carbonyl iron, supporting the diet-induced part. The paper does not report increased hepcidin mRNA in genetically iron-overloaded mice; its Introduction instead describes iron overload in USF2 knockout mice that lack hepcidin transcripts. Page numbers are not available in our copy. (LLM, conf=0.87)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
Every source the paper cites for this claim was checked and supports it.
In the paper
“decreased in mice with anemia caused by bleeding or hemolysis or in mice with hypoxemia due to decreased ambient oxygen”
What the sources say
- Supportedcites [8] Nicolas, 2002, J. Clin. Invest. source
In “Hepcidin gene expression is decreased after experimentally induced anemia,” the paper reports reduced liver hepcidin mRNA after bleeding and reduced hepcidin expression after PHZ-induced hemolytic anemia. In “Hepcidin gene expression is tightly controlled by hypoxia,” it reports downregulation in mice exposed to reduced oxygen pressure in a hypobaric chamber. The hypoxic reduction was clear after two and four days, though results varied after twelve days. (LLM, conf=0.93)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“in the most common form of hemochromatosis, that caused by mutations in the HFE gene”
What the sources say
- Not checked — no full text of the sourcecites [11] source
- Could not verifycites [12] sourceExperimental — accuracy not yet measured
The Results and discussion (page unavailable) compare urinary hepcidin in patients with well-controlled hereditary hemochromatosis with levels in patients with anemia of inflammation, but do not say hepcidin production is diminished relative to healthy people. A search for HFE mutations found no passage identifying the hemochromatosis patients as having HFE-related disease. (LLM, conf=0.76)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“IL-6 infusion rapidly increased hepcidin excretion (Figure 4B); within 2 hours after the infusion, urinary hepcidin levels were 7.5-fold higher on average than at 0 hours”
plaindirectn = 6- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“serum iron decreased on average 34% and transferrin saturation decreased 33% in comparison to preinfusion values”
plaindirectn = 6- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“TNFα markedly suppressed hepcidin mRNA levels by a mechanism that did not involve IL-6 regulation”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“both the effects of LPS on primary human hepatocytes and the effects of M-LPS on Hep3B cells were completely reversed when IL-6-neutralizing Ab's were added”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“median haptoglobin mRNA was 9.3-fold higher in turpentine-treated WT mice but only 1.9-fold higher in IL-6 KO mice”
plainn = 13- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The inflammatory and iron pathways of hepcidin stimulation respond rapidly, with major hepcidin increase detectable within 1 day in both humans and mice”
plaindirectn = 5 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“hepcidin mRNA was increased in the livers of LPS-treated mice and in LPS-treated hepatocytes”
What the sources say
- Not checked — no full text of the sourcecites [3] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“There is a single human hepcidin gene whose essential role in iron homeostasis was confirmed by identifying homozygous frameshift or nonsense mutations in affected individuals with severe juvenile hemochromatosis”
What the sources say
- Not checked — no full text of the sourcecites [9] source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“in transgenic mice overexpressing hepcidin-1 (4), transplacental and intestinal iron transport was blocked, and the mice died at birth from severe iron deficiency unless given parenteral iron supplementation”
What the sources say
- Not checked — no full text of the sourcecites [4] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These observations suggest that human hepcidin is the functional equivalent of hepcidin-1 in mice.”
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Overexpression of the other known murine hepcidin gene, hepcidin-2, had no effect on iron metabolism in mice”
What the sources say
- Not checked — no full text of the sourcecites [6] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Hepcidin production was also diminished in another form of juvenile hemochromatosis due to mutations in the hemojuvelin gene”
What the sources say
- Not checked — no full text of the sourcecites [10] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Hepatic hepcidin mRNA levels in mice were shown to increase in response to increased dietary iron”
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In IL-6 KO mice, however, hepcidin mRNA was suppressed, likely due to the negative regulation of hepcidin synthesis by other acute-phase cytokines”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“changes in serum iron concentrations reflected the pattern of hepcidin induction: turpentine treatment caused serum iron decrease in WT mice, but no change in iron levels was detected in IL-6 KO mice”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the decrease in iron supply becomes a bottleneck for hemoglobin synthesis and eventually results in anemia”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“When the rate of iron release from macrophages drops, plasma iron concentrations rapidly decrease”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“there are at least three major and distinct pathways of regulation of hepcidin: regulation by inflammation, dependent on IL-6; regulation by iron, dependent on some other factor, perhaps transferrin saturation; and suppression of hepcidin production during hypoxia and anemia”
hedgeddirectn = 5- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“transgenic overexpression of IL-6 in mice (36) and repeated administration of IL-6 in rats and cancer patients (33) has been reported to cause anemia”
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper relies on this without support.
IL-6 KO mice do not produce functional IL-6.
“Two pairs of IL-6 -/- (IL-6 KO) mice on a C57BL/6 background”
The paper relies on this without support.
Hepatic hepcidin mRNA levels reflect hepcidin synthesis or activity.
“Median hepcidin-1 expression in the liver increased 12-fold”
The paper relies on this without support.
Turpentine-induced inflammation in mice is a valid model of human inflammatory hypoferremia.
“we used the turpentine-induced mouse model of inflammation”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“increased concentrations of hepcidin then inhibit ferroportin activity”
From Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis (2021) · cites this paper as [52]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“leading to depletion of iron in plasma and extracellular fluid (hypoferremia).”
From Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis (2021) · cites this paper as [52]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As a consequence of this interaction, the absorption of iron from the diet is reduced due to hepcidin mediated reduction of ferroportin expression in enterocytes, thereby resulting in a reduction of circulating iron levels which is further aggravated by the inhibition of iron export from macrophages by the same mechanism (Nemeth et al., 2004a; Kemna et al., 2005; Roy et al., 2007; Theurl et al., 2”
From Iron at the interface of immunity and infection (2014) · cites this paper as Nemeth et al., 2004a
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“but is also an acute phase protein upregulated by inflammatory cytokines, notably IL-6 [18–20].”
From Rapidly Escalating Hepcidin and Associated Serum Iron Starvation Are Features of the Acute Response to Typhoid Infection in Humans (2015) · cites this paper as [19]
The cited source says what the claim attributes to it.
In the citing paper
“Infection and inflammation induce hepcidin, predominantly through the effects of the cytokine interleukin-6 (IL-6) [52]”
From Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis (2021) · cites this paper as [52]
The cited source says what the claim attributes to it.
In the citing paper
“Blockade of IL-6 receptor signaling prevented the hepatocyte-derived generation of hepcidin, which interferes with iron absorption (Nemeth et al., 2004”
From Targeting Interleukin-6 Signaling in Clinic (2019) · cites this paper as Nemeth et al., 2004
In the citing paper
“Interleukin-6 (IL-6) is the main cytokine that stimulates hepcidin synthesis during infection19 and inflammation, but other factors can also contribute, including activin B20, type I interferons (IFNs)21,22 and BMP2 (REF. 23).”
From Iron homeostasis in host defence and inflammation (2015) · cites this paper as [19]
In the citing paper
“Proinflammatory cytokines induced by inflammation can stimulate anemia of inflammation by limiting serum iron and increasing cellular iron stores by modulating the expression and activity of various iron regulatory proteins including hepcidin, FPN, ferritin, and the iron importer divalent metal transporter 1 (DMT1) [25–30].”
From The utility of iron chelators in the management of inflammatory disorders (2015) · cites this paper as [25]
In the citing paper
“However, hepcidin is overexpressed in inflammatory disease and is an early inflammatory marker [245,341-345].”
In the citing paper
“during an inflammatory episode interleukin-6 (IL-6) signals to the liver to release the hormone hepcidin, which promotes iron accumulation in phagocytic cells by inducing degradation of the iron exporter ferroportin (Fpn1) (Nemeth et al., 2004).”
From The Impact of Dietary Transition Metals on Host-Bacterial Interactions (2018) · cites this paper as Nemeth et al., 2004
In the citing paper
“The inflammatory increase in hepcidin is mainly caused by increased concentrations of IL-6 (interleukin-6) [19], inducing the transcription of the hepcidin gene through the JAK2/STAT3 [20][21][22] pathway.”
From Iron and infection (2018) · cites this paper as [19]
In the citing paper
“The role of IL-6 is important in many models of infection and inflammation [19,24] but in some models other cytokines may partially replace its stimulatory effect on hepcidin [17].”
From Iron and infection (2018) · cites this paper as [19]
In the citing paper
“One main contributing factor to pathologic iron homeostasis is interleukin (IL)-6 mediated induction of hepcidin expression through the Janus kinase/signal transducer and activator of transcription 3 (JAK/STAT3) pathway [154].”
From Iron in immune cell function and host defense (2021) · cites this paper as [154]
In the citing paper
“During inflammation, HAMP is induced in hepatocytes alongside a battery of other acute‐phase proteins, downstream of interleukin‐6 and toll‐like receptor signalling‐associated pathways. 98”
From The battle for iron in enteric infections (2020) · cites this paper as [98]
In the citing paper
“To correct this, all animals were conditioned on a low-iron diet (2-4 ppm iron; Teklad diet TD.80396, Envigo) for 5-7 days prior to, and throughout the duration of, all experiments.”
From Hepcidin-mediated iron sequestration protects against bacterial dissemination during pneumonia (2017) · cites this paper as [43]
In the citing paper
“Accordingly, IL6 is a key mediator of inflammation-driven iron handling, as it induces the production of hepcidin, the master regulator of iron homeostasis [4].”
In the citing paper
“It has been suggested that the COVID-19 related inflammation may be the main cause of COVID-19 associated iron disorders, as an inflammation-driven dysregulation of iron homeostasis is well established [4, 6, 7].”
In the citing paper
“The study of hepcidin regulation in mice housed under standard conditions is confounded by the high iron content of most commercial mouse chow blends.”
From Hepcidin and Host Defense against Infectious Diseases (2015) · cites this paper as [16]
In the citing paper
“Sustained elevation of hepcidin expression, as occurs in many inflammatory states, results in anemia due to reduced availability of iron for erythropoiesis, a condition previously known as “anemia of chronic disease” and more accurately renamed as “anemia of inflammation” [16,22,23].”
From Hepcidin and Host Defense against Infectious Diseases (2015) · cites this paper as [16]
In the citing paper
“In animal models, diverse inflammatory and infectious stimuli, including Streptococcus species, Pseudomonas aeruginosa, Aspergillus fumigatus, influenza, turpentine, and lipopolysaccharide (LPS) robustly induce hepcidin in the liver via the induction of IL-6, resulting in rapid reduction in serum iron levels [16,19–21].”
From Hepcidin and Host Defense against Infectious Diseases (2015) · cites this paper as [16]
In the citing paper
“In the context of inflammation, IL-6 and IL-22 stimulate HAMP expression via specific receptors signaling through signal transducer and activator of transcription (STAT)-3, while alpha-1 antitrypsin may do so via HJV and matriptase-2 [69–71].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [70]
In the citing paper
“During neuroinflammation, glial cells are activated, which perturbs iron homoeostasis.34,35”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [35]
In the citing paper
“Serum sTR concentration reflects total erythroid activity and iron status and has been shown to reflect plasma iron turnover and erythroid transferrin uptake if iron deficiency is not present (22,25).”
From Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point (2014) · cites this paper as [22]
In the citing paper
“Serum sTR concentration reflects total erythroid activity in rats and humans and has been shown to reflect plasma iron turnover and erythroid transferrin uptake very closely if iron deficiency is not present (22).”
From Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point (2014) · cites this paper as [22]
In the citing paper
“We found that the hepatocytelike cells of the adenomas expressed very high levels of hepcidin 100 and speculated that our results could be generalized-that induction of hepcidin expression in response to inflammation might explain the anemia of chronic disease.”
From Forging a field: the golden age of iron biology. (2008) · cites this paper as [197]
In the citing paper
“In mice, HFE2 is localized to the surface of periportal hepatocytes, and HFE2-mutant mice display iron loading and a striking decrease in hepcidin upregulation in response to increased iron from exogenous sources, compared with controls (217).”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [217]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“Six healthy volunteers collected first morning urine for 9 days.”
“Five subjects took 65 mg of iron (as ferrous sulfate) for 3 days, and their urinary hepcidin was monitored before, during, and after iron supplementation.”
Citations
Cites
A new mathematical model for relative quantification in real-time RT-PCR
Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S. N., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,836
Weiss, G., & Goodnough, L. T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041809 · Cited by 3,800
Hepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008922200 · Cited by 2,168
Self-citationAndrews, N. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912233412607 · Cited by 2,130
Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., & Loréal, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008923200 · Cited by 1,697
Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
Ganz, T. (2003) · Blood · doi:10.1182/blood-2003-03-0672 · Cited by 1,544
Self-citationHepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein
Nemeth, E., Valore, E. V., Territo, M., Schiller, G., Lichtenstein, A., & Ganz, T. (2003) · Blood · doi:10.1182/blood-2002-10-3235 · Cited by 1,417
Self-citationLEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity
Krause, A., Neitz, S., Mägert, H.-J., Schulz, A., Forssmann, W.-G., Schulz-Knappe, P., & Adermann, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01920-7 · Cited by 1,324
Age-Associated Increased Interleukin-6 Gene Expression, Late-Life Diseases, and Frailty
Ershler, W. B., & Keller, E. T. (2000) · Annual Review of Medicine · doi:10.1146/annurev.med.51.1.245 · Cited by 1,282
Research works printed but not linked: 2
- Means, 1999, Int. J. Hematol., 70, 7
- Barille, 2000, Eur. Cytokine Netw., 11, 546
Cited by
Sorted by citations
Items 2,101–2,200 of 2,683
The Role of Hepcidin in Regulation of Iron Balance in Bats
Stasiak, I. M. (2012) · The Atrium (University of Guelph) · Cited by 2
Gut microbiota as a therapeutic target in sepsis-induced multi-organ dysfunction: a review
Zhao, X., Ma, T., Yu, J., & Hu, Y. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1823125 · Cited by 2
Serum Interleukin-6 Levels as a Biomarker in Trauma
Kalenderer, Ö., & Erkuş, S. (2023) · Biomarkers in disease · doi:10.1007/978-3-031-07395-3_32 · Cited by 2
Pathophysiology of anemic syndrome in celiac disease and its therapeutic treatment
Oreshko, L. S., Ledentsova, S. S., Seliverstov, P. V., Salikova, S. P., & Сергеевна, И. Е. (2023) · Medical alphabet · doi:10.33667/2078-5631-2023-28-13-18 · Cited by 2
Puerto, A., Zakzuk, N. R. A., Anichiarico, W., Alvis‐Guzmán, N., & Zakzuk, J. (2025) · Biomédica · doi:10.7705/biomedica.7467 · Cited by 2
Milton, R., McLaughlin, A. P., Mariani, N., Kose, M., Zajkowska, Z., Lombardo, G., Nikkheslat, N., Perucha, E., & Mondelli, V. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.101029 · Cited by 2
Nutritional Landscape of Iron in Cardiovascular Disease
Shen, X., Zhong, M., Lin, Z., Wang, Y., Fang, X., Min, J., & Wang, F. (2025) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.06.016 · Cited by 3
Hepcidin Isoforms in Chronic Obstructive Pulmonary Disease Compared with the General Population
Hardang, I. M., Benth, J. Š., Moe, M. K., Kononova, N., Søyseth, V., & Einvik, G. (2025) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfaf095 · Cited by 2
Wang, T., Hu, W., Zhou, J., Fu, L., Xie, N., Yun, F., Piao, J., Lin, J., Chen, D., Qu, F., et al. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-02113-w · Cited by 2
COPD and kidney disease: not so far apart?
Stratan, I., Covanţev, S., Mathioudakis, A. G., & Corlăteanu, A. (2026) · Respiratory Medicine · doi:10.1016/j.rmed.2026.108761 · Cited by 2
Dash, D., & Koiri, R. K. (2026) · Advanced Gut & Microbiome Research · doi:10.1155/agm3/3202391 · Cited by 2
Coronary Artery-Specific Changes in Patients with Chronic Kidney Disease
Hanke, J., Romejko, K., & Niemczyk, S. (2026) · Cells · doi:10.3390/cells15090765 · Cited by 2
Das, S., Rejish Kumar, V. J., Pradhan, C., & Pillai, D. (2026) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2026.111432 · Cited by 2
Dynamics of Virulence of Commensals: Preventive Phenotypical Mutability
Chepur, S. V., Nn, P., Sayganov, S. A., Chubar, O. V., Сергеевна, Б. Л., & Litvinenko, I. (2023) · Biology Bulletin Reviews · doi:10.1134/s207908642306004x · Cited by 2
Potential activity of nanomaterials to combat SARS-CoV-2 and mucormycosis coinfection
Mahapatra, C., Jadhav, S., Kumar, P., Roy, D. N., Kumar, A., & Paul, M. K. (2024) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2024.2423359 · Cited by 2
Hepcidin: A potent antimicrobial peptide involved in iron homeostasis
Soofiyani, S. R., Soltani, E., Nejad, M. K., Ghanbari, R., & Memar, M. Y. (2024) · Gene Reports · doi:10.1016/j.genrep.2024.102082 · Cited by 3
Zhu, F., Ren, L., Cheng, W., Zhou, H., Li, Y., Liu, N., Rong, G., Liu, Y., Yu, P., Lv, J., et al. (2025) · Small · doi:10.1002/smll.202412093 · Cited by 2
Myokines as a Factor of Physiological Inflammation
Zakharova, A. N., Милованова, К. Г., Krivoshchekov, S. G., & Капилевич, Л. В. (2024) · Human Physiology · doi:10.1134/s0362119724701019 · Cited by 2
HFE-Related Hemochromatosis May Be a Primary Kupffer Cell Disease
Kouroumalis, E., Tsomidis, I., & Voumvouraki, A. (2025) · Biomedicines · doi:10.3390/biomedicines13030683 · Cited by 2
Aamir, M. S., Faizullah, F., Khan, M. W. Z., Azeem, T., & Khan, M. A. (2025) · Clinical Medicine Insights Case Reports · doi:10.1177/11795476251342637 · Cited by 2
Ferreira, J. T., Bicho, M., Faustino, P., & Serejo, F. (2025) · Viruses · doi:10.3390/v17101302 · Cited by 3
Study the relationship between hepcidin and IL-6 in patients infected Entamoeba histolytica
Abd, Z. N., & Al-Hadraawy, S. K. (2023) · AIP conference proceedings · doi:10.1063/5.0114875 · Cited by 2
Kolasa, A., Ręka, G., Radziejowska, Z., Bielak, A., Janiszewska, M., & Drabko, K. A. (2023) · Acta Haematologica Polonica · doi:10.5603/ahp.a2023.0017 · Cited by 2
Gambaran Interleukin 6 dan Hepidin pada Penyakit Kronis yang Dapat Menyebabkan Anemia
Rorimpandey, N. G., Rambert, G. I., & Wowor, M. F. (2023) · Medical Scope Journal · doi:10.35790/msj.v5i1.45131 · Cited by 2
Evaluation of iron metabolism in hospitalized COVID-19 patients
Lefèbvre, T., Boutten, A., Raulet-Bussian, C., Raynor, A., Manceau, H., Puy, H., Moulouel, B., Schmitt, C., Timsit, J., Lefort, A., et al. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117509 · Cited by 2
Diagnostic Value of Hepcidin in Sepsis: A Systematic Review and Meta-Analysis
Zhang, J., Zheng, Z., Ren, L., Wang, C., Li, Y., Hu, X., Zhang, J., Jing, X., & Jin, Y. (2024) · Journal of Intensive Care Medicine · doi:10.1177/08850666241267261 · Cited by 2
Hepcidin promotes oral ulcer healing via amphiregulin production in rats
Taguchi, N., Hitomi, S., Sato, H., Hayashi, Y., Shibuta, I., Iwata, K., Shirota, T., & Shinoda, M. (2024) · Journal of Dental Sciences · doi:10.1016/j.jds.2024.12.001 · Cited by 2
Evaluation and Treatment of Iron Deficiency for the Practicing Oncologist
Tatake, I. J., & Freed, J. A. (2025) · JCO Oncology Practice · doi:10.1200/op-25-00386 · Cited by 2
Maternal obesity during pregnancy disrupts iron homeostasis and promotes fetal hypoxia in the mouse
Córdova-Casanova, A., Inzani, I., Hufnagel, A., Giussani, D. A., Fernandez‐Twinn, D. S., & Ozanne, S. E. (2025) · The Journal of Physiology · doi:10.1113/jp288635 · Cited by 2
Severe Kala-azar and seric level of IL-6: case reports
Brito, G. D. R., Marreiros, A. D. S., Araujo, I. F. B. D., Júnior, R. G. D. S., Sene, I. D. S., & Bráz, D. C. (2020) · Journal of Health & Biological Sciences · doi:10.12662/2317-3076jhbs.v8i1.3035.p1-4.2020 · Cited by 2
Mandal, S., Maji, M., Bhat, N. K., Negi, G., & Agarwal, S. (2020) · Iraqi Journal of Hematology · doi:10.4103/ijh.ijh_19_20 · Cited by 2
Malattia, C., & Martini, A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-384929-8.00037-x · Cited by 2
Bustinduy, A. L., Richter, J., & King, C. H. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-7959-7.00057-9 · Cited by 2
Zakharova, I. N., Tarasova, I. S., Chernov, V. M., Борисовна, М. Е., & Vasilyeva, T. M. (2016) · Педиатрическая фармакология · doi:10.15690/pf.v12i6.1494 · Cited by 2
Trace element status of the patients with alopecia areata
Nikolaeva, T. V. (2016) · Russian Journal of Skin and Venereal Diseases · doi:10.18821/1560-9588-2016-19-3-148-151 · Cited by 2
Analysis of Prevalence of Anemia according to Severity of Atopic Dermatitis
Yun, D., Chang, J., & Rhew, K. (2020) · Korean Journal of Clinical Pharmacy · doi:10.24304/kjcp.2020.30.4.264 · Cited by 2
Malattia, C., & Martini, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812102-3.00035-x · Cited by 2
Portas, B., de Souza, A. F. A., Mazzucatto, B. C., Wosiacki, S. R., Taffarel, M. O., de Macedo, M. F., Merlini, N. B., & Marcusso, P. F. (2021) · Research Society and Development · doi:10.33448/rsd-v10i2.10842 · Cited by 2
Erythropoiesis-stimulating agents for anemia in rheumatoid arthritis
Martí-Carvajal, A. J., & Agreda-Pérez, L. H. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000332.pub2 · Cited by 2
Smith, F. M., & Kosman, D. J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.09.527936 · Cited by 2
Harifi, G., Chatelus, E., Sordet, C., Gottenberg, J., & Sibilia, J. (2010) · Revue du Rhumatisme · doi:10.1016/s1169-8330(10)70006-5 · Cited by 1
A Review of Wet Cupping’s Effects on Oxidative Stress and Insulin Resistance
Yu, I., Hur, J., Cho, J.-H., Yoo, H.-R., Choi, J., & Park, M. S. (2025) · 대한한의학회지 · doi:10.13048/jkm.25029 · Cited by 1
Vyas, S., Suman, S., Kapoor, A., & Nema, S. (2018) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20182044 · Cited by 1
“Inflammatory cytokines IL-6 was able to strongly stimulate hepcidin expression and as consequence such indicator could be responsible for hypoferriemia accompanied with chronic inflammatory diseases, this is accordance with the report of kato et al, Nemeth et al.(13,14) in the subgroup of IDA, a negative correlation b…”
ResultGorshkova, E. A., Zvartsev, R. V., Друцкая, М. С., & Gubernatorova, E. O. (2019) · Molecular Biology · doi:10.1134/s0026898419050070 · Cited by 1
Pathogenetic and substitution correction of anemia in patients with malignant neoplasms
Романенко, Н. А., Alborov, A. E., Семенович, Б. С., Shilova, E. R., Волошин, С. В., & Чечеткин, А. В. (2020) · Oncohematology · doi:10.17650/1818-8346-2020-15-3-95-106 · Cited by 1
Effects of eltrombopag on mesenchymal stem cells in immune thrombocytopenia purpura
Will, B. (2022) · British Journal of Haematology · doi:10.1111/bjh.18101 · Cited by 1
Goryainova, N. V., Vydyborets, S., Derpak, Y., Kucher, O., & Moroz, H. (2023) · Family medicine European practices · doi:10.30841/2786-720x.1.2023.277472 · Cited by 1
Barbullushi, A., Kristo, A., Lika, A., Bali, D., Toçi, E., & Godo, A. (2024) · International Journal of Biomedicine · doi:10.21103/article14(1)_oa6 · Cited by 1
Pollio, G., Rosa, L., Costanzo, A. M., Paesano, R., Tripepi, G., & Valenti, P. (2024) · Biochemistry and Cell Biology · doi:10.1139/bcb-2024-0061 · Cited by 1
Hacışahinoğulları, H., Günver, M. G., Yalın, G. Y., Selçukbiricik, Ö. S., Üzüm, A. K., & Gül, N. (2024) · Biomarkers in Medicine · doi:10.1080/17520363.2024.2342240 · Cited by 2
Husieva, S. A., Osyodlo, G. V., Goncharov, I. P., Antonyuk, O. Y., Husiev, A. V., Orlov, V. M., Кmiet, I. А., Malysh, I. V., Tkachenko, S. I., Hlushko, А. Y., et al. (2025) · Military Medicine · doi:10.1093/milmed/usaf064 · Cited by 1
Fujiwara, T., & Harigae, H. (2025) · Molecular and Cellular Biology · doi:10.1080/10985549.2025.2553648 · Cited by 1
“13 16 Conversely, hepcidin production is suppressed by erythrofer-rone released by erythroblasts in response to erythropoietin.”
Microbiome-derived metabolites in cancer-associated anemia: An underexplored mechanistic link
Wang, Z., & Wang, F. (2025) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v16.i3.110305 · Cited by 1
Rah, B., Rafiq, R., Sharafain, J., Muhammad, J. S., Taneera, J., & Hamad, M. A. (2025) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-025-09997-y · Cited by 4
Altered Gut Microbiota in Pediatric Quiescent Crohn’s Disease Patients with Iron Deficiency Anemia
Gordon, E., Goc, J., Grier, A. R., Thomas, C., Bank, J. L. C., Artis, D., Longman, R., Sonnenberg, G. F., Scherl, E., Sockolow, R., et al. (2025) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaf295 · Cited by 1
Xu, Y., Dai, Y.-L., Lei, H., Yuan, Y., Hu, T.-L., Wei, X., Lan, Y., & Guo, L.-M. (2026) · BMC Pediatrics · doi:10.1186/s12887-025-06470-2 · Cited by 1
“TNF-αsynergistically enhances this inflammatory effect while suppressing erythropoiesis, collectively impacting blood iron levels [28].”
Sherief, D., Nosair, N. A. E.-A., Abdelhameed, A. M., Sadaka, E., Othman, A. A. A., & Elgamal, R. (2026) · World Journal of Clinical Oncology · doi:10.5306/wjco.v17.i1.112801 · Cited by 1
Ahmed, H. M., Rehman, U. U., & Owais, M. (2026) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-026-02320-z · Cited by 1
Metabolism of Iron Ions and Its Role in Regulating the Functions of Immune System Cells
Orlova, E. G., & Gorbunova, O. L. (2026) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093026020018 · Cited by 1
Praeger‐Jahnsen, L., Aasbrenn, M., Kamper, R. S., Schultz, M., Hansen, P., Hansen, S., Pressel, E., Rasmussen, J., Christensen, M., Ditlev, S. B., et al. (2026) · BMC Geriatrics · doi:10.1186/s12877-026-07638-w · Cited by 1
“Levels also increased with decreasing kidney function, consistent with impaired renal clearance as previously reported [8, 14, 25, 35].”
The Hidden Burden of Undiagnosed Psychological Stress Among Patients with Iron Deficiency Anemia
Aggarwal, M., Mehadwan, S. S., Dubey, N., Kumar, A., Vishwakarma, V. K., Khan, M. A., Sagar, R., Kanwar, R., Kumar, A., & Yadav, H. N. (2026) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-026-02529-x · Cited by 1
Brandt, S., Takala, J. A., & Lepper, P. (2009) · Springer eBooks · doi:10.1007/978-0-387-77383-4_44 · Cited by 1
“5-fold within two hours after infusion, whereas IL-6 knockout mice (in contrast to control mice) failed to induce hepcidin in response to turpentine induced peritonitis [15].”
BackgroundInfluentialRole of Hepcidin in Dysregulation of Iron Metabolism and Anemia of Chronic Diseases
Singh, B. M., Arora, S., Gupta, S., & Saxena, A. (2012) · BiblioBoard Library Catalog (Open Research Library) · doi:10.5772/27286 · Cited by 1
“Role of hepcidin in pathogenesis of anemia by virtue of decreased iron release from macrophages and enterocytes as well as induction of its expression by IL-6 is well established [13, 74].”
BackgroundAnémie de réanimation : physiopathologie et prise en charge
Lasocki, S., Gaillard, T., & Rineau, E. (2013) · Réanimation · doi:10.1007/s13546-013-0695-6 · Cited by 1
“L’inflammation, et en particulier l’IL-6, stimule la synthèse d’hepcidine [21], qui est responsable du profil du bilan martial observé dans les anémies inflammatoires (diminution du fer sérique et augmentation de la ferritinémie) [22], réalisant ainsi une carence martiale « fonctionnelle ».”
BackgroundThe Effects of Acute Exercise on Hepcidin in Women
Newlin, M. K., Williams, S., McNamara, T., & Haymes, E. M. (2010) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000386536.43953.cd · Cited by 1
“induce inflammation, further illustrate the role of this cytokine (82).”
BackgroundResultInfluentialAnemia in the elderly: an important clinical problem
Cliquet, M. G. (2013) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.5581/1516-8484.20130026 · Cited by 1
“Anemia in these diseases is caused by the inhibition of the effect of erythropoietin in red cell precursors (interleukins such as interleukin-6 and Tumor Necrosis Factor)(4), or by blocking of iron in macrophage cells (role of hepcidin)(15) or even a reduction in the red cell lifespan.”
BackgroundSchrier, S. L. (2010) · Blood · doi:10.1182/blood-2010-02-267294 · Cited by 1
The iron sensor: macrophage, hepatocyte, both?
Fleming, R. E. (2005) · Blood · doi:10.1182/blood-2005-07-2673 · Cited by 1
Tanaka, T., Hagihara, K., Shima, Y., Narazaki, M., Ogata, A., & Kumanogoh, A. (2011) · Drug Development Research · doi:10.1002/ddr.20480
“High levels of hepcidin block iron transporter ferroportin 1 on macrophages, hepatocytes, and gut epithelial cells, leading to hypoferremia and anemia of inflammation [Nemeth et al., 2004].”
BackgroundErythropoietin Deficiency and Late-Life Anemia
Kanapuru, B., Artz, A. S., & Ershler, W. B. (2007) · Springer eBooks · doi:10.1007/978-0-387-49506-4_9 · Cited by 1
Wartość diagnostyczna i zastosowanie kliniczne biomarkerów oraz ferrytynemii w chorobie Gauchera
Lorenz, F., Skotnicki, A. B., & Machaczka, M. (2014) · Acta Haematologica Polonica · doi:10.1016/j.achaem.2014.04.004 · Cited by 1
“[17] Nemeth E, Rivera S, Gabayan V, et al.”
BackgroundHfe : une molécule à l’interface entre immunité et métabolisme du fer ?
Rohrlich, P., Kanellopoulos, J., & Lemonnier, F. A. (2006) · médecine/sciences · doi:10.1051/medsci/200622124 · Cited by 1
Hepcidin is Linked to Hypoferremia in Patients With Rheumatic Valve Disease
Akçay, M., Yeter, E., Ayhan, H., Durmaz, T., Keleş, T., Kasapkara, H. A., Bilen, E., & Bozkurt, E. (2014) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029614523501 · Cited by 1
“Released in response to inflammation, IL-6 stimulates hepcidin production in the liver.(5,6) Increased levels of hepcidin, on the other hand, inhibits iron absorption from the intestines and release of iron from the reticuloendothelial system to circulation, thereby resulting in reduced levels of iron in blood.”
BackgroundIron-Restricted Erythropoiesis in a Population of Elderly Hospitalized Anemic Patients
Karlsson, T. (2012) · Open Journal of Blood Diseases · doi:10.4236/ojbd.2012.22006 · Cited by 1
“An inflammatory response increases expression of the hepatic protein hepcidin in an interleukin-6dependent manner [5].”
BackgroundChae, S.-J., & Chung, J. (2008) · Journal of the Korean Society of Food Science and Nutrition · doi:10.3746/jkfn.2008.37.6.721 · Cited by 1
“01% acetic acid를 첨가하여 재용해하는 과정을 거쳐 hepcidin-rich fraction을 얻었다(22).”
Iron overload due to excessive supplementation
Barton, J. C., Edwards, C. Q., Phatak, P. D., Britton, R. S., & Bacon, B. R. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511777035.036 · Cited by 1
Ritz, E. (2006) · Cited by 1
Facteurs de croissance hématopoïétiques
Chaaba, H., & Piperno-Neumann, S. (2011) · Springer eBooks · doi:10.1007/978-2-8178-0021-9_53 · Cited by 1
Diet and lifestyle interventions to improve co-morbid conditions of chronic kidney disease
Tomayko, E. J. (2011) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign) · Cited by 1
Dwivedi, S. (2016) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v4i3.39 · Cited by 1
“proposed, including abnormalities of iron absorption (9) and release from macrophages (10) as well as malfunction of the cytokine network (11-16) ,”
BackgroundAnémies par troubles du métabolisme du fer
Bauduer, F. (2009) · Encyclopédie médico-chirurgicale. Hématologie · doi:10.1016/s1155-1984(09)50262-2 · Cited by 1
Disruption of Iron Regulation after Radiation and Donor Cell Infusion
Karoopongse, E., Marcondes, A. M., Yeung, C. C. S., Holman, Z. J., Kowdley, K. V., Campbell, J. S., & Deeg, H. J. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.03.031 · Cited by 1
“Concurrently, tissue injury inflicted by cytotoxic transplant conditioning results in the release of cytokines, including IL-6, which would be expected to up-regulate hepcidin and oppose iron accumulation [8,9].”
BackgroundHafez, M. H., Abdelhamid, Y., & Ahmed, A. I. (2010) · African Journal of Nephrology · doi:10.21804/14-1-763 · Cited by 1
The Pediatric Patient with Chronic Kidney Disease
Warady, B. A., & Chadha, V. (2005) · Elsevier eBooks · doi:10.1016/b978-1-4160-0158-4.50018-5 · Cited by 1
Iron Overload: Diagnosis, Complications, and Management
Brissot, P. (2016) · Springer eBooks · doi:10.1007/978-3-319-30352-9_11 · Cited by 1
Gesquiere, I., Matthys, C., & der Schueren, B. V. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-804011-9.00038-8 · Cited by 1
Genetik metabolischer und viraler Lebererkrankungen
Herta, T., Fischer, J., & Berg, T. (2017) · Die Gastroenterologie · doi:10.1007/s11377-016-0128-y · Cited by 1
Aetiology of Iron Deficiency in Children
Gupta, A. K. (2017) · Springer eBooks · doi:10.1007/978-981-10-5178-4_5 · Cited by 1
Bhatnagar, A., Parihar, S., & Parihar, A. V. (2018) · Journal of Oral Health and Community Dentistry · doi:10.5005/jp-journals-10062-0021 · Cited by 1
Serum hepcidin levels in active and inactive Behcet’s disease
Şahin, M., Dikker, O., Yıldırmak, S., Usta, M., Vardar, M., Vurgun, E., Çiçek, Y., Durmuşcan, M., Altun, Z., & Baran, F. (2018) · Ortadoğu Tıp Dergisi · doi:10.21601/ortadogutipdergisi.413997 · Cited by 1
“IL-6 is the main cytokine mediating hepcidin synthesis [1, 19, 23, 25].”
BackgroundPharmaconutrition としての微量元素・ビタミン投与の是非
智, 村., 和彦, 深., & 安原, 洋. (2017) · The Japanese Journal of SURGICAL METABOLISM and NUTRITION · doi:10.11638/jssmn.51.6_339 · Cited by 1
Olusola, A. O. (2020) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2020.26.004364 · Cited by 1
Searching for additional markers of impaired iron metabolism in diabetes mellitus
Мусина, Н. Н., Саприна, Т. В., Prokhorenko, T. S., & Zima, A. P. (2020) · Problems of Endocrinology · doi:10.14341/probl12277 · Cited by 1
Barffour, M. A., & Humphries, D. L. (2020) · Springer eBooks · doi:10.1007/978-3-030-56913-6_2 · Cited by 1
Nutrition and anemia in chronic kidney disease
Wang, A. Y.-M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818540-7.00035-5 · Cited by 1
The Anemia of Chronic Inflammation
Adamson, J. W. (2007) · Springer eBooks · doi:10.1007/978-0-387-49506-4_4 · Cited by 1
“The molecules that specifically were involved in upregulating hepcidin expression included IL-6 and lipopolysaccharide (17, 18 ).”
BackgroundA HISTORY CASE OF TOCILIZUMAB USAGE IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
Denisova, R. V., Alexeeva, E. I., & Sleptsova, T. V. (2012) · Вопросы современной педиатрии · doi:10.15690/vsp.v11i4.381 · Cited by 1
Tan, L., Lv, W., Chen, Y., Dong, J., Mao, D., & Wei, R. (2024) · ACS Omega · doi:10.1021/acsomega.4c01147 · Cited by 1
Silva-Caso, W. G., Kym, S., Merino‐Luna, A., Aguilar-Luis, M. Á., Tarazona-Castro, Y., Carrillo‐Ng, H., de Villa, E. B.-V., Aquino-Ortega, R., & del Valle-Mendoza, J. (2024) · Biomedicines · doi:10.3390/biomedicines12071609 · Cited by 1
“Likewise, serum hepcidin is elevated by inflammatory cytokines, particularly IL-6 [23].”
BackgroundMarchand, V., Laplane, L., Valensi, L., Plo, I., Aglave, M., Silvin, A., Pasquier, F., Porteu, F., Vainchenker, W., Selimoglu‐Buet, D., et al. (2024) · iScience · doi:10.1016/j.isci.2024.111522 · Cited by 1
“39 Our results identi-fied another indirect contribution of IL6 to anemia-related inflam-mation through the promotion of CAL secretion by maturing monocytes, positioning CAL as an IL6 amplifier.”
Metadata
- Authors
- Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T.
- Affiliations
- University of California, Los Angeles (US)
- Rigshospitalet (DK)
- Corresponding author
- Ganz, Tomas
- Venue
- Journal of Clinical Investigation
- Published
- 2004-05-01
- Volume
- 113
- Issue
- 9
- Pages
- 1271-1276
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC398432
- OpenAlex
- W2132155262
- Cited by
- 2,650
- References
- 40
- Citations by year
- 2026: 100 · 2025: 97 · 2024: 93 · 2023: 117 · 2022: 115 · 2021: 145 · 2020: 134 · 2019: 130 · 2018: 130 · 2017: 141 · 2016: 103 · 2015: 135 · 2014: 132 · 2013: 140 · 2012: 137
- FWCI
- 55.20
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- David Geffen School of Medicine, University of California, Los Angeles
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Keywords
- interleukin-6, hepcidin, iron regulation, inflammation, cytokine signaling, liver, iron regulatory hormone
- MeSH terms
- Anemia, Animals, Cell Line, Cells, Cultured, Gene Expression Regulation, Humans, Inflammation, Iron, Kupffer Cells, Mice, Inbred C57BL, Monocytes, RNA, Messenger, Interleukin-6, Mice, Knockout, Iron Metabolism Disorders, Reverse Transcriptase Polymerase Chain Reaction, Hepatocytes, Antimicrobial Cationic Peptides, Mice, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
